You are here

Primo Nutraceuticals Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
PRMO
CSE Index: 
Currency: 

About Primo Nutraceuticals, Inc.

Primo Nutraceuticals Inc. Cannabis Production, Processing, Retail & Branding - Primo Nutraceuticals Inc. ("Primo" or the "Company") provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo provides fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. In addition to the Company's flagship hemp project in Oregon State and the Greenhouse campus in Washington State, Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo's management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets - offering "Thrive," "Primo," and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

You are here

Primo Nutraceuticals Inc. (PRMO)

SEDAR Information

Company Info

Address
Suite 440, 890 West Pender St.
Vancouver, BC V6C 1J9
Canada
Phone
1-877-517-7816
Email
info@primoceuticals.com
Website
http://primonutraceuticals.com/
Listing date
Friday, August 31, 2018
Transfer Agent
Integral Transfer Agency Shareholder Services
Email
info@primoceuticals.com

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
10,465,952
Reserved for Issuance: 
225,535

Bulletins

25/08/2020

2020-0830 – Consolidation - Primo Nutraceuticals Inc. (PRMO)

Le 25 aout/August 2020

Primo Nutraceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common shares for fifteen (15) pre-consolidation common shares.

As a result, the outstanding shares of the company will be reduced to approximately 10,465,952 common shares.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

tech-tuesday.png

Tech Tuesdays

Tuesday, September 22, 2020 -
4:15pm to 5:00pm
image_2.png

The Impact of the Pandemic on Women's Advancement during Recovery

Tuesday, September 29, 2020 -
12:00pm to 1:00pm
2020-09-30-The-Psychedelics-Renaissance_Website.png

The Psychedelics Renaissance

Wednesday, September 30, 2020 -
1:00pm to 3:00pm